General Nephrology – Glomerulonephritis

E VAUGHAN1, A TIKU1, C POLLOCK1,2 1Royal North Shore Hospital, St Leonards, Australia, 2Kolling Insitute of Medical Research, St Leonards, Australia Background: Alemtuzumab, an anti-CD52 pan-lymphocyte depleting monoclonal antibody approved for management of relapsing-remitting multiple sclerosis (MS) has been associated...
  • 8 June 2018
Read More
S ROGER1, D PACKHAM2,3,  R SHEPHERD2, H HEERSPINK4 1Gosford Hospital, Gosford, Australia, 2Dimerix Limited, Melbourne, Australia, 3Melbourne Renal Research Group, Reservoir, Australia, 4University Medical Center, Groningen, Netherlands Aim: To determine the effect of dual inhibition of angiotensin II receptor type...
  • 8 June 2018
Read More
Y WARDHANI1, H PRASANTO2, I KUSWADI2 1Student of Nephrology Consultant Program, Sardjito General Hospital, , Indonesia, 2Staff of Division of Nephrology and Hypertension, Department of Internal Medicine, Sardjito General Hospital, Indonesia Background: Immunoglobulin A nephropathy has been identified as the...
  • 8 June 2018
Read More
S ROGER1, D PACKHAM2,3, R SHEPHARD2, D POWER4 1Gosford Hospital, Gosford, Australia, 2Dimerix Limited, Melbourne, Australia, 3Melbourne Renal Research Group, Reservoir, Australia, 4Austin Health, Heildelberg, Australia Aim: To test the hypothesis that simultaneous antagonism of AT1R and CCR2 is beneficial...
  • 8 June 2018
Read More
S NAYAR1, B PAWAR1, S THOMAS1, D  FERNANDES1, PGEORGE1, SBRADY1, C SAJIV1 1Alice Springs Hospital, Alice Springs, Australia Background: Rituximab, an anti-CD20 B cell depleting monoclonal antibody, is prescribed off-label for Systemic Lupus Erythematosus (SLE) for various indications. Aim: To...
  • 8 June 2018
Read More
W YEUNG1,2, E DOWNIE1, J RIORDAN1,3, K MURALI1,3 1Wollongong Hospital, Wollongong , Australia, 2University of New South Wales, Kensington, Australia, 3University of Wollongong, Wollongong, Australia Background: Propylthiouracil-induced ANCA positivity is well known but systemic vasculitis and lupus-like syndrome (LLS) caused...
  • 8 June 2018
Read More
M TIONG1, A PHAM1, S WILSON1,2,3, R WALKER1,2, A CHRYSOSTOMOU1,2,4 1Alfred Health, Melbourne, Australia, 2Monash University, Melbourne, Australia, 3Baker IDI, Melbourne, Australia, 4Epworth HealthCare, Melbourne, Australia Background: HIV associated lupus like glomerulonephritis is an uncommon but well described cause of...
  • 8 June 2018
Read More
V SRINIVASA1, G KAN1, V MANICKAM1, K SRIVASTAVA1, J LY1, SFAYEZ1 1Townsville Hospital, Townsville, Australia Background: Macrophage activation syndrome (MAS) is a rare and life-threatening disorder described as a autoinflammatory phenomenon. It is a variant of haemophagocytic lymphohistiocytosis (HLH) and...
  • 8 June 2018
Read More
V HERON1, M NICHOLSON1, S WILKINSON1, A YOUNG1, S GOVINDARAJULU1, S VENUTHURPALLI1 1Renal Service, Darling Downs Hospital And Health Service, Toowoomba, Australia Background: As the use of anti–tumour necrosis factor-alpha (TNF-α) treatments for rheumatic and systemic autoimmune disorders increases, so...
  • 8 June 2018
Read More
P LIU1, H TAN1, H LI2, C LIM1,  J CHOO1 1Department of Renal Medicine, Singapore General Hospital, Singapore, 2Division of Research, Singapore General Hospital, Singapore Aim: We aimed to evaluate predictors of onset of infection in a multiethnic Asian population...
  • 8 June 2018
Read More
Categories